Clear Up Confusion About Outpatient Treatments for COVID-19

We're hearing about lots of oral "cocktails" to treat COVID-19 in outpatients...with azithromycin, dexamethasone, ivermectin, etc.

It's tempting to try to repurpose affordable, relatively safe meds...grasping for something to help.

Currently the only authorized option for outpatients is the monoclonal antibody bamlanivimab...given as an IV infusion to those at high risk of serious COVID-19 complications.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote